SAF, Your line of reasoning, IMO opinion, argue
Post# of 148279
Your line of reasoning, IMO opinion, argues that the approval processes are objective and fair.
In spite of Dr. Pourhassan’s generosity toward the FDA, I don’t believe that is the case.
Exhibit 1: remdesevir EUA
Exhibit 2 : convalescent plasma after NIH thumbs down
Exhibit 3: expansion of remdesevir EUA.
I am not of the mind that if at first we don’t succeed, Eff it, it wasn’t worth it.
It is worth it. I am aware that I am now beating the beleaguered and still dead horse.
Nonetheless, I believe, and IMO the thousands of articles addressing CCR5 and everything from Alzheimer’s to Zika support my assertion, that leronlimab will transform medicine.
My wife is one of the post-Lyme/makes no sense/go see a shrink patients that medicine has dismissed and dismissed because the doctors don’t know what they don’t know (no offense intended. I don’t know what I do t know either).
We (ok, Cytodyn and associated physicians, I am an eager groupie) are on the precipice of transforming medicine and lives.
So whether the U.K. acts September 9 in response to the Cytodyn submission, the fight will continue.